Overview

Pharmacokinetics of Insulin Detemir in Subjects With Type 1 Diabetes

Status:
Completed

Trial end date:
2003-02-01

Target enrollment:

Participant gender:

Summary

This trial is conducted in Japan. The aim for this trial is to investigate the pharmacodynamics and pharmacokinetics of insulin detemir and insulin NPH in Japanese subjects with type 1 diabetes mellitus.

Phase:

Phase 1

Details

Lead Sponsor:

Novo Nordisk A/S

Treatments:

Insulin
Insulin Detemir
Insulin, Globin Zinc
Insulin, Isophane
Isophane insulin, beef
Isophane Insulin, Human